Hereditary neuropathies

Current Opinion in Neurology

Volumn 16, Issue 5, 2003, Pages 613-622

  Berciano, José ^a   Combarros, Onofre ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Axonal degeneration; Charcot Marie Tooth disease; Demyelination; Hereditary brachial palsy neuropathy; Hereditary motor and sensory neuropathies; Hereditary neuropathies

Indexed keywords

CORTICOSTEROID; VINCRISTINE;

ANAMNESIS; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ELECTROPHYSIOLOGY; GENE DELETION; GENE DUPLICATION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; NEUROPATHY; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT;

ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; HUMANS;

EID: 0142155686     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200310000-00008     Document Type: Review

References (80)

1. Reilly MM. Genetically determined neuropathies. J Neurol 1998; 245:6-13.
2. Kleopa KA, Scherer S. Inherited neuropathies. Neurol Clin North Am 2002; 20:679-709. This outstanding review summarizes genetic, clinical and electrophysiological data on CMT disorders.
3. Shy ME, Garbern JY, Kamholz J. Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol 2002; 1:110-118. An excellent review analysing the molecular pathophysiology of CMT disorders with very instructive pictures.
4. Reilly MM, Hanna MG. Genetic in neuromuscular disease. J Neurol Neurosurg Psychiatry 2002; 72 (Suppl. II):ii12-ii21. A simple but very useful revision for clinicians.
5. Kuhlenbäumer G, Young P, Hünermund G, et al. Clinical features and molecular genetics of hereditary peripheral neuropathies. J Neurol 2002; 249:1629-1650. A comprehensive review including all the syndromes in which neuropathy is the sole or primary part of disease.
6. Pareyson D. Diagnosis of hereditary neuropathies in adult patients. J Neurol 2003; 250:148-160. A good paper analysing the clinical diagnostic approach to hereditary neuropathies in adult patients.
7. Tanaka Y, Hirokawa N. Mouse models of Charcot-Marie-Tooth disease. Trends Genet 2002; 18:39-44. An authoritative revision of CMT animal models.
8. Dyck PJ, Chance P, Lebo R, Carney AJ. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, et al., editors. Peripheral neuropathy, 3rd ed. Philadelphia: W.B. Saunders Co.; 1993. pp. 1094-1136.
9. Harding AE. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain 1995; 118:809-818.
10. Kurihara S, Adachi Y, Wada K, et al. An epidemiological genetic study of Charcot-Marie-Tooth disease in Western Japan. Neuroepidemiology 2002; 21:246-250.
11. Morocutti C, Colazza GB, Soldati G, et al. Charcot-Marie-Tooth disease in Molise, a Central-Southern region of Italy: an epidemiological study. Neuroepidemiology 2002; 21:241-245.
12. Combarros O, Calleja J, Polo JM, Berciano J. Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 1987; 75:9-12.
13. Nelis E, Van Broeckhoven C, De Jonghe P, et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Genet 1996; 4:25-33.
14. Berciano J, García A, Combarros O. Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication. Muscle Nerve 2003; 27:34-39. The first longitudinal description of the initial signs and symptoms in secondary CMT 1A cases.
15. Vinci P, Perelli SL. Foot drop, foot rotation, and plantarflexor failure in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 2002; 83:513-516.
16. Martinoli C, Schenone A, Bianchi P, et al. Sonography of the median nerve in Charcot-Marie-Tooth disease. Am J Roentgenol 2002; 178:1553-1556.
17. Hattori N, Yamamoto M, Yoshihara T, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations on myelin related proteins (PMP22, MPZ, Cx32): a clinicopathological study of 205 Japanese patients. Brain 2003; 126:134-151. An extensive and excellent clinical study of CMT disorders summarizing the experience of the Japanese Study Group for Hereditary Neuropathy.
18. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy. Brain 1980; 103:809-818.
19. García A, Combarros O, Calleja J, Berciano J. Charcot-Marie-Tooth disease type 1A with duplication in infancy and early childhood: a longitudinal clinical and electrophysiological study. Neurology 1998; 10:1061-1067.
20. Krajewski KM, Lewis RA, Fuerst DR, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000; 123:1516-1527.
21. Berciano J, García A, Calleja J, Combarros O. Clinico- electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease type 1A duplication. Neuromusc Disord 2000; 10:419-424.
22. Fernández-Torre JL, García-Alcalde M, Alvarez V. Effects of antiretroviral therapy in patients with Charcot-Marie-Tooth disease type 1A. J Neurol 2002; 249:940-941.
23. Palumbo C, Masa R, Panico MB, et al. Peripheral nerve extracellular matrix remodeling in Charcot-Marie-Tooth type I disease. Acta Neuropathol 2002; 104:287-296. This study examines ECM remodeling in the peripheral nerves of CMT1-affected patients.
24. Misko A, Ferguson T, Notterpek L. Matrix metalloproteinase mediated degradation of basement membrane proteins in Trembler J neuropathy nerves. J Neurochem 2002; 83:855-894. This study examines ECM remodeling in Trembler J nerves.
25. Robertson AM, Perea J, McGuigan A, et al. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J Anat 2002; 200:377-390. A review paper in which the authors compare the peripheral nerve pathology seen in My41 mice, which carry the mouse pmp22 gene, with previously described transgenic mice over-expressing the human PMP22 protein and Trembler J mice that have a P16L substitution.
26. Maier M, Berger P, Suter U. Understanding Schwann cell-neurone interactions: the key to Charcot-Marie-Tooth disease. J Anat 2002; 200:357-366. Another paper analysing experimental data concerning the pathophysiological role of the Schwann cell-neuron interaction in the appearance of axonal loss in animal models of CMT 1A.
27. •].
28. Norreel JC, Vinay L, Fontes M, Clarac F. Close relationship between motor impairments and loss of functional motoneurons in a Charcot-Marie-Tooth type 1A model. Neuroscience 2003; 116:695-703. This and the previous paper performed by the same group show that PMP22 overexpression in a murine model of CMT 1A induces dysmyelination, the level of motor deficit being correlated with the number of functional motoneurons evaluated by retrograde labeling from the muscles.
29. Street VA, Meekins G, Lipe HP, et al. Charcot-Marie-Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx32 genes. Neuromusc Disord 2002; 12:643-650.
30. Watanabe M, Yamamoto N, Ohkoshi N, et al. Corticosteroid responsive asymmetric neuropathy with a myelin protein zero gene mutation. Neurology 2002; 59:767-769.
31. o protein are closely related to the abnormal myelination in CMT 1B.
32. Street VA, Goldy JD, Golden AS, et al. Mapping of Charcot-Marie-Tooth type 1C to chromosome 16p identifies a novel locus for demyelinating neuropathies. Am J Hum Genet 2002; 70:244-250.
33. Street VA, Bennett CL, Goldy JD, et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003; 60:22-26. This study reports on the molecular identification of the gene mutation causing CMT 1C.
34. Sambuughin N, de Bantel A, McWilliams S, Sivakumar K. Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene. Neurology 2003; 60:506-508. Specific mutations of the PMP22 gene causing CMT 1 and deafness are reported.
35. Planté-Bordeneuve V, Said G. Dejerine-Sottas disease and hereditary demyelinating polyneuropathy. Muscle Nerve 2002; 26:608-621. An essential paper to understand the complex DSD nosology.
36. Dejerine J, Sottas L. Sur la névrite interstitielle hypertrophique et progressive de l'enfance. Affection souvent familiale et a début infantile, caractérisée par une atrophie musculaire des extrémités, avec troubles marqués de la sensibilité et ataxie des mouvements et relevant d'une névrite interstitielle hypertrophique a marche ascendente, avec lésions médullaires consécutives. CR Soc Biol (Paris) 1893; 45:63-96.
37. Gabreëls-Festen A. Dejerine-Sottas syndrome grown to maturity: an overview of genetic and morphological heterogeneity and follow-up of 25 patients. J Anat 2002; 200:341-356. A good example of the complex DSD nosology.
38. Li J, Krajewski K, Shy ME, Lewis RA. Hereditary neuropathy with liability to pressure palsy. The electrophysiology fits the name. Neurology 2002; 58:1769-1773. The authors prospectively addressed the question of whether there is a distal myelinopathy in HNPP.
39. Pou Serradell A, Monells J, Téllez MJ, et al. Neuropathies héréditaires sensibles à la presión: étude de six familles espagnoles. Rev Neurol (Paris) 2002; 158:579-588. A large clinical HNPP series with good clinico-electrophysiological descriptions.
40. Van de Watering RAC, Gabreëls-Festen AAWM, Timmerman V, et al. Hereditary neuropathy with liability to pressure with a small deletion interrupting the PMP22 gene. Neuromusc Disord 2002; 12:651-655.
41. Kalfakis N, Panas M, Karadima G, et al. Hereditary neuropathy with liability to pressure palsies emerging during vincristine therapy. Neurology 2002; 59:1470-1471.
42. Baxter RV, Ben Othmane, Rochelle JM, et al. Ganglioside-induced differentiation-associated protein 1 is mutant in Charcot-Marie-Tooth type 4A disease. Nat Genet 2002; 30:22-25.
43. Cuesta A, Pedrola L, Sevilla T, et al. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 2002; 30:22-25.
44. Nelis E, Erdem S, Van der Bergh, et al. Mutations in GDAP1. Autosomal recessive with demyelination and axonal axonopathy. Neurology 2002; 59:1865-1872.
45. Senderek J, Bergmann C, Ramaekers VT, et al. Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 2003; 126:642-649.
46. Boerkoel CF, Takashima H, Nakagawa M, et al. CMT4: identification of a Hispanic GDAP1 founder mutation. Ann Neurol 2003; 53:400-405.
47. Nicholson G, Ouvrier R. GDAP1 mutations in CMT4: axonal and demyelinating phenotypes? The exception 'proves the rule'. Neurology 2002; 59:1835-1836.
48. Berciano J, Combarros O, Figols J, et al. Hereditary motor and sensory neuropathy type II. Clinicopathological study of a family. Brain 1986; 109:897-914.
49. Bolino A, Muglia M, Conforti FL, et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 2000; 25:17-19.
50. Othmane KB, Johson E, Menold M, et al. Identification of a new locus for autosomal recessive Charcot-Marie-Tooth disease with focally folded myelin on chromosome 11p15. Genomics 1999; 62:344-349.
51. Nelis E, Erdem S, Tan E, et al. A novel homozygous missense mutation in the myotubularin-related protein 2 gene with recessive Charcot-Marie-Tooth disease with irregularity folded myelin sheaths. Neuromusc Disord 2002; 12:869-873.
52. Berger P, Bonneick S, Willi S, et al. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease 4B1. Hum Mol Genet 2002; 11:1569-1579. This paper demonstrates that the known disease-associated MTMR2 mutations lead to dramatic reduced phosphatase activity, suggesting that MTMR2 phosphatase activity is crucial for the proper function of peripheral nerves.
53. Senderek J, Bergmann C, Weber S, et al. Mutation of SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 2003; 12:349-356. The molecular identification of the gene mutation causing CMT4B2.
54. Boerkoel CF, Takashima H, Stankiewicz P, et al. Periaxin mutations cause recessive Dejerie-Sottas neuropathy. Am J Hum Genet 2001; 68:325-333.
55. Guilbot A, Williams A, Ravisé N, et al. A mutation in periaxin expression is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001; 10:415-421.
56. Takashima H, Boerkoel CF, De Jonghe P, et al. Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 2002; 51:709-715. This study illustrates a prominent sensory neuropathy resulting from periaxin gene mutations, and suggests a role for the carboxyl terminal domain of the periaxin protein.
57. Williams AC, Brophy PJ. The function of the Periaxin gene during repair in a model of CMT4F. J Anat 2002; 200:323-330. This review paper looks at a mouse model of CMT4F showing that periaxin-null mice undergo peripheral nerve remyelination, but regulation of peripheral myelin thickness is disrupted.
58. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ. Cell 2001; 105:587-597.
59. Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72:722-727. The molecular identification of the gene mutation causing CMT2B.
60. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000; 67:37-46.
61. Brownlees J, Ackerley S, Grierson AJ, et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum Mol Genet 2002; 11:2837-2844. This study demonstrates that aberrant neurofilament assembly and transport can induce neurological disease, and further implicates defective neurofilament metabolism in the pathogenesis of human neurodegenerative diseases.
62. Jordanova A, De Jonghe, Boerkoel CF, et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 2003; 126:590-597.
63. McEntagart M, Dunstan M, Bell C, et al. Clinical and genetic heterogeneity in peroneal muscular atrophy associated with vocal cord paralysis. J Neurol Neurosurg Psychiatry 2002; 73:762-765.
64. Santoro L, Manganelli F, Di Maio L, et al. Charcot-Marie-Tooth disease type 2C: a distinct genetic entity. Clinical and molecular characterization of the first European family. Neuromusc Disord 2002; 12:399-404.
65. DeSandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear envelope proteins, cause autosomal recessive axonal neuropathy in human Charcot-Marie-Tooth disorder type 2 and mouse. Am J Hum Genet 2002; 70:726-736.
66. Chaouch M, Allal Y, DeSandre-Giovannoli A, et al. The phenotypic manifestations of autosomal recessive Charcot-Marie-Tooth disease due to mutation in Lamin A/C gene. Neuromusc Disord 2003; 13:60-67. This study describes the phenotype of AR-CMT2 A.
67. Nicholson G, Gorbett A. Slowing of central conduction in X-linked Charcot-Marie-Tooth neuropathy shown by brain stem auditory evoked potentials. J Neurol Neurosurg Psychiatry 1996; 61:43-46.
68. Bähr M, Andres F, Timmerman V, et al. Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn20Ser mutation in the connexin 32 gene. J Neurol Neurosurg Psychiatry 1999, 66:202-206.
69. Paulson HL, Gaebern JY, Hoban TF, et al. Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann Neurol 2002; 52:429-434. This study describes two patients who developed transient clinical central nervous dysfunction accompanied by diffuse and symmetrical white matter abnormalities after returning from a brief stay at an altitude above 8000 feet.
70. Schelhaas HJ, van Engelen BGM, Gabreëls-Festen AAWM, et al. Transient cerebral white matter lesions in a patient with connexin 32 missense mutation. Neurology 2002; 59:2007-2008.
71. Kawakami H, Inoue K, Sakakihara I, Nakamura S. Novel mutation in X-linked Charcot-Marie-Tooth disease associated with CNS impairment. Neurology 2002; 59:923-926.
72. Kleopa KA, Yum SW, Scherer SS. Cellular mechanisms of connexin 32 mutations associated with CNS manifestations. J Neurosci Res 2002; 68:522-534. The authors describe different defects in intracellular trafficking of the Cx32 'CNS mutants', which do not affect the expression of other oligodendrocyte connexins, and specifically Cx45.
73. Windebank AJ. Inherited recurrent focal neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, et al., editors. Peripheral neuropathy, 3rd ed. Philadelphia: W.B. Saunders Co.; 1993. pp. 1565-1679.
74. Pellegrino JE, Rebbeck TR, Brown MJ, et al. Mapping of hereditary neuralgic amyotrophy (familial brachial plexus neuropathy) to distal chromosome 17q. Neurology 1996; 46:1128-1132.
75. Watts GD, O'Briant KC, Borreson TE, et al. Evidence for genetic heterogeneity in hereditary neuralgic amyotrophy. Neurology 2001; 56:675-678.
76. Klein CJ, Dyck PJB, Friedenberg SM, et al. Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J Neurol Neurosurg Psychiatry 2002; 73:45-50. In this clinical, electrophysiological and pathological study, the authors address the question of whether attacks in HBPN are attributable to altered immunity.
77. Thomas PK. Hereditary sensory neuropathies. Brain Pathol 1993; 3:157-163.
78. Bejaoui K, Uchida Y, Yasuda S, et al. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis. J Clin Invest 2002; 110:1301-1308. This comprehensive study analyses the effects of the mutations identified in two HSN1 families on the function of serine palmitoyl transferase.
79. Toscano E, Simonati A, Indo Y, Andria G. No mutation in the TRKA (NTRK1) gene encoding a receptor tyrosine kinase for nerve growth factor in a patient with hereditary sensory and autonomic neuropathy type V. Ann Neurol 2002; 52:224-227.
80. Zamba-Papanicolau E, Christodoulou K, Christodoulou C, et al. Hereditary motor neuronopathies. Rev Neurol (Paris) 2002; 158:1220-1224.